Human immunodeficiency virus screening among pregnant women in France : Results from the 1995 national perinatal survey.
The aim of the study was to assess how the French legislation requiring physicians to offer human immunodeficiency virus screening routinely at the beginning of prenatal care has been implemented and to explore areas in which improvement is required.
The survey included all births in France during a 7-day period in February 1995.
A total of 12,341 women were asked whether they knew whether they had undergone a human immunodeficiency virus antibody test before or during the pregnancy.
Factors that could have influenced their knowledge of whether they had been tested were also assessed.
Of the women questioned, 87.3% stated that they had been tested before or during pregnancy, 7.6% said that they had not been tested, and 5.1% stated that they did not know whether a test had been performed.
Among those who said that they had not been tested before the pregnancy in question, 84.9% reported that they were tested during the pregnancy.
The multivariate analysis revealed that women from North Africa differed significantly from French women in both unawareness of screening status and the proportion who reported not being screened (odds ratio 2.1 with 95% confidence interval 1.6-2.9 and odds ratio 2.4 with 95% confidence interval 1.8-3.1, respectively).
There was, however, no significant difference between women from sub-Saharan Africa and French women in these variables. (...)
Mots-clés Pascal : SIDA, Virose, Infection, Sérologie, Virus immunodéficience humaine, Lentivirus, Retroviridae, Virus, Séropositivité, Gestation, Dépistage, Diagnostic, Prénatal, Homme, Femelle, France, Europe, Epidémiologie, Politique sanitaire, Prévention, Immunopathologie, Immunodéficit, Surveillance sanitaire
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Serology, Human immunodeficiency virus, Lentivirus, Retroviridae, Virus, Seropositivity, Pregnancy, Medical screening, Diagnosis, Prenatal, Human, Female, France, Europe, Epidemiology, Health policy, Prevention, Immunopathology, Immune deficiency, Sanitary surveillance
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0190677
Code Inist : 002B05C02D. Création : 16/11/1999.